Zyversa Therapeutics, Inc.
ZVSA
Revenue
0.00
0.000.00%
-Assets
19.47M
▼-2.18M▼-10.07%
3 Months ChangeLiabilities
10.85M
▲421.82k▲4.05%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 8-K
ID: 0001493152-24-043066
2024-09-16
Form 8-K
ID: 0001493152-24-036453
2024-08-09
Form 10-Q
ID: 0001493152-24-031002
2024-08-01
Form 8-K
ID: 0001493152-24-029868
2024-05-15
Form 10-Q
ID: 0001493152-24-019517
2024-04-25
Form 8-K
ID: 0001493152-24-015938
2024-04-17
Form 8-K
ID: 0001493152-24-015041
2024-03-08
Form 8-K
ID: 0001493152-24-009437
2024-03-01
Form 8-K
ID: 0001493152-24-008508
2023-12-22
Form 8-K
ID: 0001493152-23-045948